Asset Details
Do you wish to reserve the book?
12 Genetic analysis of primary and recurrent adult granulosa cell tumors of the ovary
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
12 Genetic analysis of primary and recurrent adult granulosa cell tumors of the ovary
Do you wish to request the book?
12 Genetic analysis of primary and recurrent adult granulosa cell tumors of the ovary
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
12 Genetic analysis of primary and recurrent adult granulosa cell tumors of the ovary
2019
Overview
ObjectivesAdult granulosa cell tumors (aGCTs) are rare ovarian tumors underpinned by the FOXL2 p.C134W mutation, with a 10–30% risk of relapse. We sought to determine the genetic alterations underpinning primary and recurrent aGCTs.MethodsThirty-five aGCTs were subjected to massively parallel sequencing targeting 468 cancer-related genes (7 primary aGCTs that did not recur >4 years, 9 primary and matched recurrent aGCTs, 10 recurrent aGCTs). These cases and additional 12 aGCTs (n=3, primary aGCTs that did not recur; n=9, recurrent aGCTs) were subjected to Sanger sequencing analysis of the TERT promoter.ResultsAll aGCTs included harbored the FOXL2 p.C134W hotspot mutation. A significantly higher frequency of TERT promoter mutations was found in recurrent (64%) than in primary aGCTs (26%; p=0.017). Moreover, aGCT recurrences harbored a higher frequency of somatic KMT2D and TP53 mutations (16%, each) than primary aGCTs with subsequent recurrences (11% and 0%) and primary aGCTs without subsequent recurrences (14% and 0%). We identified a higher frequency of CDKN2A/B homozygous deletions in recurrent (16%) than in primary aGCTs (6%), and other gene alterations restricted to recurrent aGCTs. Pathway analysis revealed that aGCTs are underpinned by genetic alterations affecting the cell cycle pathway. Clonal decomposition of matched primary and recurrent aGCTs showed that aGCTs display multiple clones at diagnosis and relapse.ConclusionsOur findings suggest that although FOXL2 plays a crucial role in the tumorigenesis of aGCTs, recurrences might be associated with genetic alterations affecting TERT, cell cycle-related genes such as TP53 and CDKN2A/B, and other cancer-related genes, including KMT2D, TET2 and EPHA5.
Publisher
Elsevier Inc,by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology,Elsevier Limited
Subject
